Wikipedia

Draft:Erdal Sağ

  • Comment: You have a lot of problems with spelling and grammar in this draft that will need fixed before it is accepted. CoconutOctopus talk 21:08, 27 November 2024 (UTC)


    • Erdal Sağ
    Born (1986-03-19) 19 March 1986 (age 38)
    Alma materHacettepe University
    Aarhus University
    Known forPediatry
    Medicine
    Rheumatology
    Scientific career
    InstitutionsPediatry
    Doctoral advisorProf Dr Seza Özen

    Erdal Sağ (born March 19, 1986) is a Turkish academic, researcher, Ppaediatric rheumatologist, research institute professor[1][2]

    Career

    edit
     
    Erdal Sag Foundation of Pediatry [3]

    1986 Kütahya/Turkey born academic, researcher, awarded pediatrician.[4]

    Prof Dr. Erdal Sağ, known with his researches on Pediatric Rheumatology .[5]. Prof Dr Dr Erdal Sag has undertaken academic studies that focused on pediatric health sciences, especially juvenile idiopathic arthritis and systemic Lupus Erythematosus.[6]

    Prof Dr. Erdal Sag’s academic studies began with a medical degree from Hacettepe University’s English program (2004-2010). He continued his further specialization in child health and completed his Doctorate on Pediatry Department of Hacettepe University in 2015. His postgraduate studies include advanced research in pediatric Paediatric rheumatology conducted at prestigious institutions such as:[7]

    • University College London (UCL), UK (2014) – Postdoctoral research in Infection, Inflammation, and Rheumatology.
    • University of Aarhus, Denmark (2018–2019) – Postdoctoral studies in biomedicine focusing on immunological aspects of rheumatic diseases.

    He is currently continue his lectures on Pediatric Rheumatology at Hacettepe University.[8]

    Academical research

    edit
     
    Prof Dr Erdal Sag with academic staff

    Prod Dr. Erdal Sag has authored over 120 widely cited publications (over 1,100 citations in Scopus Medicine Journal).[9] His work has been published at the Congress of the European Society of Paediatric Rheumatology (PReS) and the European League Against Rheumatism (EULAR) conferences.[10][11]

    Awards

    edit

    Dr. Erdal Sag's research on "T cell depletion profiles" could effect future Pediatric Examinations on that topic .[12]


    Selected research publications

    edit

    1-Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry[13]

    2- Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia Pestis [14]

    3- Juvenile idiopathic arthritis: lymphocyte activation Gene-3 is a central immune receptor in children with Oligoarticular subtypes[15]

    4-Changing Disease Course of Crimean-Congo Hemorrhagic Fever in Children, Turkey[16]

    5-Evaluation of Choroidal thickness, choroidal vascularity index and Peripapillary retinal nerve fiber layer in patients with juvenile systemic lupus erythematosus.[17]

    6- Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach[18]

    7- Chronic non-bacterial osteomyelitis and immune checkpoint molecules[19]

    References

    edit
    1. ^ "Circum Vitale,P rof Dr Erdal Sağ English".
    2. ^ "Avesis, Prof Dr Erdal Sağ".
    3. ^ "Pediatry Foundation Info Page,2024".
    4. ^ "Ministry Of Health of Turkiye, 2024".
    5. ^ "Erdal Sağ CV".
    6. ^ "Pediatric Romotology Foundation Web Site,2024".
    7. ^ "Pediatrik Romotoloji Vakfı Yayınları Resmi Web Sitesi,Doç Dr Erdal Sağ,Ankara-2022".
    8. ^ "Scientific & Professional Activities,Prof Dr Erdal Sağ,Hacettepe University Department of Pediatry,Ankara,2024".
    9. ^ "Scopus,E.Sağ,2024".
    10. ^ "Eular Paediatric-Rheumatology Committee List".
    11. ^ "Avesis,Hacettepe,2024".
    12. ^ "Sağ,Erdal,Google Scholar,2024".
    13. ^ "Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry".
    14. ^ Park, Yong Hwan; Remmers, Elaine F.; Lee, Wonyong; Ombrello, Amanda K.; Chung, Lawton K.; Shilei, Zhao; Stone, Deborah L.; Ivanov, Maya I.; Loeven, Nicole A.; Barron, Karyl S.; Hoffmann, P.; Nehrebecky, M.; Akkaya-Ulum, Y. Z.; Sag, E.; Balci-Peynircioglu, B.; Aksentijevich, I.; Gül, A.; Rotimi, C. N.; Chen, H.; Bliska, J. B.; Ozen, S.; Kastner, D. L.; Shriner, D.; Chae, J. J. (2020). "Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis". Nature Immunology. 21 (8): 857–867. doi:10.1038/s41590-020-0705-6. PMC 7381377. PMID 32601469.
    15. ^ "Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes".
    16. ^ "Changing Disease Course of Crimean-Congo Hemorrhagic Fever in Children, Turkey,Emerging Infectious Diseases, 2020".
    17. ^ Lupus Medical Maganize, A Ağın, S Kadayıfçılar, HE Sönmez, A Baytaroğlu, SERAP Demir, ERDAL Sağ, SEZA Özen, B Eldem (2019). "Evaluation of choroidal thickness, choroidal vascularity index and peripapillary retinal nerve fiber layer in patients with juvenile systemic lupus erythematosus". Lupus. 28 (1): 44–50. doi:10.1177/0961203318814196. PMID 30466353.{{cite journal}}: CS1 maint: multiple names: authors list (link)
    18. ^ Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach. Rheumatology Journal. 2021. {{cite book}}: |first1= missing |last1= (help)CS1 maint: multiple names: authors list (link)
    19. ^ Clinical Rheumatology,Ummusen Kaya Akca, Erdal Sag , Busra Aydın,2024.
    edit

    1-X

    2-Researchgate

    3-Avesis Academical Data System Erdal Sag

    4-Pediatrik Romotoloji Derneği

    5-European Alliance of Associations for Rheumatology

    This page will be placed in the following categories if it is moved to the article namespace.
    Categories:
    Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Erdal_Sağ&oldid=1260181870"